EP0981324B1 - Schweisshemmende creme mit verbesserten trockenen hautgefühl - Google Patents

Schweisshemmende creme mit verbesserten trockenen hautgefühl Download PDF

Info

Publication number
EP0981324B1
EP0981324B1 EP98920983A EP98920983A EP0981324B1 EP 0981324 B1 EP0981324 B1 EP 0981324B1 EP 98920983 A EP98920983 A EP 98920983A EP 98920983 A EP98920983 A EP 98920983A EP 0981324 B1 EP0981324 B1 EP 0981324B1
Authority
EP
European Patent Office
Prior art keywords
antiperspirant
composition
weight
triglycerides
gram
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
EP98920983A
Other languages
English (en)
French (fr)
Other versions
EP0981324A1 (de
Inventor
Jennifer Elaine Hilvert
Christine Marie Putman
David Frederick Swaile
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Procter and Gamble Co
Original Assignee
Procter and Gamble Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Procter and Gamble Co filed Critical Procter and Gamble Co
Publication of EP0981324A1 publication Critical patent/EP0981324A1/de
Application granted granted Critical
Publication of EP0981324B1 publication Critical patent/EP0981324B1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q15/00—Anti-perspirants or body deodorants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/04—Dispersions; Emulsions
    • A61K8/042—Gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A61K8/26—Aluminium; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A61K8/28—Zirconium; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/37—Esters of carboxylic acids
    • A61K8/375—Esters of carboxylic acids the alcohol moiety containing more than one hydroxy group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/58—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing atoms other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur or phosphorus
    • A61K8/585—Organosilicon compounds

Definitions

  • the present invention relates to antiperspirant cream compositions with improved dry feel characteristics.
  • the present invention relates to antiperspirant cream compositions comprising drying agents used in combination with volatile silicone emollients and select triglyceride gellants.
  • topical antiperspirant products that are commercially available or otherwise known in the antiperspirant art. Most of these products are formulated as sprays, roll-on liquids, creams, or solid sticks, and comprise an astringent material, e.g. zirconium or aluminum salt, incorporated into a suitable topical carrier. These products are designed to provide effective perspiration and odor control while also being cosmetically acceptable during and after application onto the axillary area or onto other areas of the skin. Aerosol sprays and solid sticks have been especially popular with consumers.
  • antiperspirant creams remain an effective alternative to antiperspirant sprays and solid sticks.
  • These creams can be applied by conventional means, or packaged into topical dispensers to make topical application more efficient and less messy. Perspiration and odor control provided by these products can be excellent. Many of these creams, however, are cosmetically unacceptable to a large number of antiperspirant users. Application of these creams can be messy, difficult to spread and wash off, and even when a cream applicator is employed, the applied areas often feel wet or sticky for several minutes after application. Many consumers have therefore preferred antiperspirant sticks for ease of administration and drier skin feel immediately after application, although the antiperspirant sticks typically leave an undesirably high residue on the skin.
  • antiperspirant cream compositions which comprise a volatile silicone solvent, particulate antiperspirant actives and a select molar ratios of certain triglyceride gellants, provides effective antiperspirant and odor control, and improved cosmetics (reduced stickiness, improved ease of spreading, reduced dry-down times, improved wash-off, reduced grittiness) during and after application onto skin.
  • the triglyceride gellant material described herein when combined with volatile silicone solvents, provides a stable structure containing a dispersion of particulate antiperspirant actives, even when higher concentrations of volatile silicones are used.
  • the present invention is directed to antiperspirant compositions in a cream formulation which have a penetration force value of from 20 gram-force to 500 gram-force.
  • These compositions comprise (a) from 20% to 80% by weight of a volatile silicone solvent; (b) from 5% to 35% by weight of a particulate antiperspirant active; (c) from 0.1% to 20% by weight of a gellant material comprising glyceryl tribehenate and other triglycerides wherein at least 75% of the fatty acid esters moieties of said other triglycerides have from 18 to 36 carbon atoms, and the molar ratio of glyceryl tribehenate to said other triglycerides is from 20:1 to 1:1; and (d) from 0.1% to 5% by weight of a drying agent selected from the group consisting of bentonite clays, hectonite clays, colloidal silicas, talc, microthene, and mixtures thereof.
  • the present invention is directed to an anti
  • the antiperspirant cream compositions of the present invention are liquid dispersions of particulate solids in a continuous water-insoluble or lipophilic phase. These cream compositions are suitable for use in roll-on or topical cream applicators, or by other conventional means of topical application, for depositing antiperspirant material onto human skin.
  • the antiperspirant cream compositions of the present invention have a penetration force value of from 20 gram ⁇ force to 500 gram ⁇ force, at 27° C, 15% relative humidity, as measured with a TA-XT2 Texture Analyzer, manufactured by Texture Technology Corp, Scarsdale, New Jersey, U.S.A. This value is the force required to move a standardized 45° cone through the product, for a distance of 10 mm, at a rate of 2 mm/second.
  • the angled cone is also available from Texture Technology Corp., as part number TA-15, and has a total cone length of about 24.7 mm, an angled cone length about 18.3 mm, a maximum diameter of the angled surface of the cone of about 15.5 mm.
  • the cone is a smooth, stainless steel construction and weights about 17.8 grams.
  • the antiperspirant cream composition of the present invention does not include solid antiperspirant stick compositions, which solid sticks have force penetration values substantially greater than 500 gram ⁇ force, typically above about 1000 gram ⁇ force.
  • the antiperspirant compositions include roll-on application, and topical application using a cream applicator device.
  • the composition of the present invention has a penetration force value of from 20 gram ⁇ force to about 100 gram ⁇ force, preferably from about 35 gram-force to about 70 gram ⁇ force.
  • the composition has a penetration force value of from 100 gram ⁇ force of 500 gram ⁇ force, preferably from 120 gram ⁇ force to 250 gram ⁇ force, more preferably from 140 gram ⁇ force to 200 gram ⁇ force.
  • antiperspirant compositions of the present invention can comprise, consist of, or consist essentially of the essential elements and limitations of the invention described herein, as well as any of the additional ingredients, components, or limitations described herein.
  • the antiperspirant composition of the present invention comprises a volatile silicone solvent at concentrations ranging from 20% to 80%, preferably from 30% to 70%, more preferably from 45% to 70%, by weight of the composition.
  • the volatile silicone solvent may be cyclic or linear.
  • Volatile silicone refers to those silicone materials which have measurable vapor pressure under ambient conditions.
  • suitable volatile silicones are described in Todd et al., “Volatile Silicone Fluids for Cosmetics", Cosmetics and Toiletries, 91:27-32 (1976).
  • Preferred volatile silicone materials are those having from 3 to 7, preferably from 4 to 5, silicon atoms.
  • Cyclic volatile silicones are preferred for use in the antiperspirant compositions herein, and include those represented by the formula: wherein n is from 3 to 7, preferably from 4 to 5, most preferably 5. These cyclic silicone materials will generally have viscosities of less than about 10 centistokes at 25°C.
  • Linear volatile silicone materials suitable for use in the antiperspirant compositions include those represented by the formula: wherein n is from 1 to 7, preferably from 2 to 3. These linear silicone materials will generally have viscosities of less than 5 centistokes at 25°C.
  • volatile silicone solvents suitable for use in the antiperspirant compositions include, but are not limited to, Cyclomethicone D-5 (commercially available from G. E. Silicones), Dow Corning 344, Dow Corning 345, and Dow Corning 200 0.5 csk (commercially available from Dow Corning Corp.), GE 7207 and 7158 (commercially available from General Electric Co.), and SWS-03314 (commercially available from SWS Silicones Corp.).
  • compositions of the present invention comprise particulate antiperspirant materials at concentrations ranging from 5% to 35%, preferably from 10% to 30%, antiperspirant active by weight of the compositions. These weight percentages are calculated on an anhydrous metal salt basis (exclusive of glycine, the salts of glycine, or other complexing agents).
  • the particulate antiperspirant materials preferably have particle sizes ranging from about 1 to about 100 microns, more preferably from about 1 to about 50 microns.
  • the particulate materials may be impalpable or microspherical in form.
  • Particulate antiperspirant materials suitable for use herein are those which comprise any compound, composition or mixture thereof having antiperspirant activity.
  • Astringent metallic salts are preferred antiperspirant materials for use herein, particularly the inorganic and organic salts of aluminum, zirconium and zinc, as well as mixtures thereof.
  • Particularly preferred are the aluminum and zirconium salts, such as aluminum halides, aluminum hydroxy halides, zirconyl oxide halides, zirconyl hydroxy halides, and mixtures thereof.
  • Preferred aluminum salts are those represented by the formula: Al 2 (OH) a Cl b ⁇ x H 2 O wherein a is from about 2 to about 5; the sum of a and b is about 6; x is from about 1 to about 6; and wherein a, b, and x may have non-integer values.
  • Processes for preparing aluminum salts are disclosed in U.S. Patent 3,887,692, Gilman, issued June 3, 1975; U.S. Patent 3,904,741, Jones et al., issued September 9, 1975; U.S.
  • Zirconium salts are also preferred for use in the antiperspirant compositions. These salts are represented by the formula: ZrO(OH) 2-a Cl a ⁇ x H 2 O wherein a is from about 1.5 to about 1.87; x is from about 1 to about 7; and wherein a and x may have non-integer values. These zirconium salts are described in Belgian Patent 825,146, Schmitz, issued August 4, 1975. Particularly preferred zirconium salts are those complexes which additionally contain aluminum and glycine, commonly known as ZAG complexes. Such ZAG complexes contain aluminum chlorhydroxide and zirconyl hydroxy chloride of the formulae described above. Such ZAG complexes are described in U.S.
  • the antiperspirant composition of the present invention comprises a gellant material comprising a select molar ratio of certain specified triglycerides.
  • the gellant material when combined with the volatile silicone solvent described hereinbefore, provides the composition with a physically stable structure within which the particulate antiperspirant materials are dispersed, and maintained as such over an extended period of time.
  • the antiperspirant composition comprises from about 0.1% to about 20%, by weight of the gellant material, wherein the gellant material comprises glyceryl tribehenate and other triglycerides, wherein at least about 75%, preferably about 100%, of the esterified fatty acid moieties of said other triglycerides each have from about 18 to about 36 carbon atoms, and wherein the molar ratio of glyceryl tribehenate to said other triglycerides is from about 20:1 to about 1:1, preferably from about 10:1 to about 3:1, more preferably from about 6:1 to about 4:1.
  • the esterified fatty acid moieties may be saturated or unsaturated, substituted or unsubstituted, linear or branched, but are preferably linear, saturated, unsubstituted ester moieties derived from fatty acid materials having from about 18 to about 36 carbon atoms.
  • the triglyceride gellant material preferably has a melting point of less than about 110°C, more preferably between about 60°C and 110°C.
  • this triglyceride-based gellant material when combined with volatile silicone solvents, and when used in the above-described molar ratio, provides a stable structure for maintaining a dispersion of particulate antiperspirant material in a topical formulation.
  • This triglyceride gellant is especially useful in maintaining the physical stability of particulate dispersions containing higher concentrations of volatile silicone solvents.
  • penetration force values for the antiperspirant compositions can be controlled by adjusting total triglyceride concentrations while maintaining the above-described molar ratios.
  • organic solvents to control penetration force values, which solvents often add cost to the formulation, introduce additional compatibility issues, and often contribute undesirable cosmetics such as prolonged stickiness, increased dry-down times, and reduced dry feel after application.
  • Preferred concentrations of the gellant material ranges from 0.5% to 15% by weight of the composition. Specific concentrations are selected depending on the desired penetration force value. For roll-on formulations having a penetration force value of from 20 gram ⁇ force to 100 gram ⁇ force, triglyceride concentrations preferably range from 1% to 5% by weight of the antiperspirant composition. For other cream formulations, including those formulations suitable for use in cream applicator devices, which have a penetration force value of from 100 gram ⁇ force to 500 gram ⁇ force, triglyceride concentrations preferably range from 4% to 20%, preferably from 4% to 10%, by weight of the antiperspirant composition.
  • a particularly preferred embodiment of the present invention are antiperspirant cream compositions described herein which are packaged in suitable cream applicator devices.
  • suitable cream applicator devices include those described in U.S. Patent 5,000,356.
  • triglyceride gellants for use in the antiperspirant compositions include, but are not limited to, tristearin, hydrogenated vegetable oil, rape seed oil, castor wax, fish oils, tripalmiten, Syncrowax® HRC and Syncrowax® HGL-C (Syncrowax® available from Croda, Inc.).
  • the antiperspirant composition of the present invention comprises a drying agent to provide improved dry skin feel. Concentrations of the drying agent range from 0.1% to 5%, more preferably from 0.3% to 3%, even more preferably from 0.5% to 2%, by weight of the composition.
  • Suitable drying agents are typically in the form of inert solid particulates, and include materials such as talc, microthene, silicates, colloidal silicas, and mixtures thereof. These materials provide benefits such as dry feel and aesthetics, especially dry feel benefits.
  • Silicates suitable for use in the antiperspirant composition include montmorillonite clays and hydrophobically treated montmorillonites, examples of which include bentonites, hectonites, colloidal magnesium silicates, and mixtures thereof.
  • Commercially available silicates include the Bentone series of hydrophobic bentonites available from NL Industries, Inc.
  • Preferred drying agents for use herein include fumed silicas, especially finely divided fumed silicas or colloidal silicas.
  • Fumed silicas are typically in the form of fluffy, white powders which comprise micron to sub-micron sized silica particulates having relatively high surface areas of from about 2.5 m 2 /gm to about 1,200 m 2 /gm.
  • Preferred fumed silicas are those having an average particle diameter of less than about 1.0 ⁇ m, and a surface area of from about 100 m 2 /gm to about 1,200 m 2 /gm.
  • Fumed silicas are a form of colloidal silicas which are typically made by hydrolyzing silicon tetrachloride at high temperatures to form fumed silicas which contain about 99.8% by weight (on a moisture free basis) of silicon dioxide.
  • Colloidal silica materials are well known in the art, and are described in Hardy, et al. "The Use of Fumed Silica in Cosmetics", 2 Cosmetic Technology 35 (1980), and R. Iler, The Chemistry of Silica (1979).
  • Colloidal silica materials suitable for use herein are available from a variety of sources, including Syloid silicas (manufactured by Davison Chemical Division of W.R. Grace), Cab-O-Sil (manufactured by Cabot Corporation), and Aerosil (manufactured by Degussa A.G.).
  • Syloid silicas manufactured by Davison Chemical Division of W.R. Grace
  • Cab-O-Sil manufactured by Cabot Corporation
  • Aerosil manufactured by Degussa A.G.
  • Cab-O-Sil is a preferred commercially available colloidal silica useful herein, with a surface area ranging from about 200 m 2 /gm to about 400 m 2 /gm.
  • the antiperspirant composition of the present invention may further comprise a nonvolatile emollient as a residue masking material.
  • a nonvolatile emollient as a residue masking material.
  • Concentrations of the optional residue masking material ranges from about 0.1% to about 40%, preferably from about 1% to about 10%, by weight of the antiperspirant composition. These optional materials are liquid at ambient temperatures, and are nonvolatile.
  • nonvolatile refers to materials which have a boiling point under atmospheric pressure of at least about 200°C.
  • Nonlimiting examples of suitable residue masking materials for use in the antiperspirant products include butyl stearate, diisopropyl adipate, petrolatum, nonvolatile silicones, octyldodecanol, phenyl trimethicone, isopropyl myristate, C12-15 ethanol benzoate, mineral oil, and PPG-14 Butyl Ether.
  • Residue masking materials are described, for example, in U.S. Patent 4,985,238.
  • Nonvolatile silicones such as Dow Corning 200 10 csk and Dow Corning 200 20 csk (available from Dow Corning Corp.) are the preferred optional residue masking materials.
  • the antiperspirant compositions of the present invention may further comprise one or more other optional materials which modify the physical characteristics of the compositions or serve as additional "active" components when deposited on the skin.
  • optional materials are known in the antiperspirant art and may be used in the antiperspirant compositions herein, provided that such optional materials are compatible with the essential materials described herein, or do not otherwise unduly impair product performance.
  • Nonlimiting examples of optional materials include active components such as bacteriostats and fungiostats, and "non-active" components such as colorants, perfumes, emulsifiers, chelants, distributing agents, preservatives, and wash-off aids.
  • active components such as bacteriostats and fungiostats
  • non-active components such as colorants, perfumes, emulsifiers, chelants, distributing agents, preservatives, and wash-off aids.
  • active components such as bacteriostats and fungiostats
  • non-active components such as colorants, perfumes, emulsifiers, chelants, distributing agents, preservatives, and wash-off aids.
  • compositions of the present invention are well known to those skilled in the art. They may be batch processes involving discrete processing steps or involving continuous processes wherein the product composition is passed between processing steps in essentially continuous increments. The process may be as simple as thoroughly mixing together all of the components at the desired temperature, typically from about -35°C to about 100°C, and then allowing the heated mixture to cool to room temperature. Specific essential and non-essential materials, at specific concentrations, are selected to produce a cream of desired aesthetics and viscosity, which deposits a suitable amount of antiperspirant active on the skin during use. In making the compositions of the present invention care must be taken to assure that the particulate antiperspirant materials are dispersed relatively uniformly throughout the composition.
  • the antiperspirant cream compositions of the present invention may be packaged in conventional antiperspirant cream containers known in the art. Such packages typically contain the cream in bulk form. The cream is then applied by hand, or by a pad or similar applicator device. These creams may also be packed in a dispenser designed to extrude or otherwise directly apply the creams to the skin.
  • the cream compositions of the present invention may by packaged in known or conventional roll-on applicators, and applied to the skin by application of the roll-on device to the skin.
  • the antiperspirant compositions of the present invention are utilized in a conventional manner to treat or prevent perspiration on areas of the human body, such as the axillary areas, which are prone to perspiration wetness. Specifically, an effective amount of any of the compositions described herein is applied topically to such areas one or more times a day. When this is done, the compositions provide effective antiperspirant performance, as well as reduced residue on the skin, and good aesthetics upon application for the user.
  • composition of the present invention. All of the listed components are combined and heated to 100 °C with agitation, and cooled to about 52°C. The composition is then filled into jars or cream applicators and allowed to cool and form a stiff cream. The penetration force value of the resulting composition is about 225 gram ⁇ force.
  • composition of the present invention.
  • the listed components are combined and heated to 100°C with agitation, and cooled to 52°C.
  • the composition is then packaged in jars or cream applicators and allowed to cool.
  • the penetration force value of the resulting composition is about 185 gram ⁇ force.
  • antiperspirant compositions described in Examples I-IV when applied to the axillary area of the user, provide effective prevention and control of perspiration wetness. These compositions remain physically stable over extended periods. These compositions also have reduced dry-down times, smoother and drier feel immediately after application, and reduced apparent residue.

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Inorganic Chemistry (AREA)
  • Dispersion Chemistry (AREA)
  • Emergency Medicine (AREA)
  • Cosmetics (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Claims (10)

  1. Transpirationshemmende Cremezusammensetzung, umfassend:
    (a) 20 bis 80 Gew.-% eines flüchtigen Siliconmatierials;
    (b) 5 bis 35 Gew.-% eines teilchenförmigen transpirationshemmenden Wirkstoffs;
    (c) 0,1 bis 20 Gew.-% eines Geliermittelmaterials, umfassend Glyceryltribehenat und andere Triglyceride, wobei mindestens 75% der Fettsäureestereinheiten der anderen Triglyceride 18 bis 36 Kohlenstoffatome aufweisen, und das Molverhältnis von Glyceryltribehenat zu den anderen Triglyceriden 20:1 bis 1:1 beträgt; und
    (d) 0,1 bis 5 Gew.-% eines Trocknungsmittels, gewählt aus der Gruppe, bestehend aus Bentonit-Tonen, Hectonit-Tonen, kolloidalen Silicas, Talk. Microthen und Mischungen hiervon; und
    wobei die transpirationshemmende Cremezusammensetzung einen Penetrationskraftwert von 20 Gramm·Kraft bis 500 Gramm·Kraft besitzt.
  2. Zusammensetzung nach Anspruch 1, wobei das flüchtige Siliconmaterial ein cyclisches Silicon ist der Formel: worin n 3 bis 7 ist.
  3. Zusammensetzung nach Anspruch 1 oder 2, umfassend weiterhin 0,1 bis 40 Gew.-% eines Rückstandsmaskierungsmaterials.
  4. Transpirationshemmende Cremezusammensetzung, umfassend:
    (a) 20 bis 80 Gew.-% eines flüchtigen cyclischen Siliconmaterials;
    (b) 5 bis 35 Gew.-% eines teilchenförmigen transpirationshemmenden Wirkstoffs;
    (c) 0,1 bis 20 Gew.-% eines Geliermittelmaterials, umfassend Glyceryltribehenat und andere Triglyceride, wobei mindestens 75% der Fettsäureestereinheiten der anderen Triglyceride 18 bis 36 Kohlenstoffatome aufweisen, und das Molverhältnis von Glyceryltribehenat zu den anderen Triglyceriden 4:1 bis 6:1 beträgt;
    (d) 0,1 bis 5 Gew.-% eines Trocknungsmittels, gewählt aus der Gruppe, bestehend aus Bentonit-Tonen, Hectonit-Tonen, kolloidalen Silicas, Talk, Microthen, und
    Mischungen hiervon; und
    (e) 0.1 bis 40 Gew.-% eines Rückstandsmaskierungsmaterials; und
    wobei die transpirationshemmende Cremezusammensetzung einen Penetrationskraftwert von 20 Gramm·Kraft bis 500 Gramm·Kraft besitzt.
  5. Zusammensetzung nach mindestens einem der vorangehenden Ansprüche, wobei die Zusammensetzung 0,5 bis 2 Gew.-% des Trocknungsmittels umfasst.
  6. Zusammensetzung nach mindestens einem der vorangehenden Ansprüche, wobei 100% der Fettsäureestereinheiten der anderen Triglyceride jeweils eine lineare, gesättigte, unsubstituierte Kohlenstoffkette mit 18 bis 36 Kohlenstoffatomen umfassen.
  7. Zusammensetzung nach mindestens einem der vorangehenden Ansprüche, wobei das kolloidale Silica Quarzstaub mit einem Oberflächenbereich von 200 m2/g bis 400 m2/g ist.
  8. Zusammensetzung nach mindestens einem der vorangehenden Ansprüche, wobei das Rückstandsmaskierungsmaterial ein nichtflüchtiges Silicon ist.
  9. Nichttherapeutisches Verfahren zur Behandlung und Vermeidung von Schweißbildung bei Menschen, umfassend die topische Anwendung auf den Achselbereich einer wirksamen Menge der transpirationshemmenden Zusammensetzung nach Anspruch 1.
  10. Nichttherapeutisches Verfahren zur Behandlung und Vermeidung von Schweißbildung bei Menschen, umfassend die topische Anwendung auf den Achselbereich einer wirksamen Menge der transpirationshemmenden Zusammensetzung nach Anspruch 4.
EP98920983A 1997-05-15 1998-05-08 Schweisshemmende creme mit verbesserten trockenen hautgefühl Expired - Lifetime EP0981324B1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US856771 1997-05-15
US08/856,771 US5843414A (en) 1997-05-15 1997-05-15 Antiperspirant cream compositions with improved dry skin feel
PCT/US1998/009156 WO1998051272A1 (en) 1997-05-15 1998-05-08 Antiperspirant cream compositions with improved dry skin feel

Publications (2)

Publication Number Publication Date
EP0981324A1 EP0981324A1 (de) 2000-03-01
EP0981324B1 true EP0981324B1 (de) 2003-09-10

Family

ID=25324474

Family Applications (1)

Application Number Title Priority Date Filing Date
EP98920983A Expired - Lifetime EP0981324B1 (de) 1997-05-15 1998-05-08 Schweisshemmende creme mit verbesserten trockenen hautgefühl

Country Status (9)

Country Link
US (1) US5843414A (de)
EP (1) EP0981324B1 (de)
JP (1) JP2001517237A (de)
CN (1) CN1262613A (de)
AT (1) ATE249195T1 (de)
AU (1) AU7369398A (de)
BR (1) BR9809825A (de)
DE (1) DE69818034T2 (de)
WO (1) WO1998051272A1 (de)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6187300B1 (en) 1997-12-17 2001-02-13 The Procter & Gamble Company Antiperspirant cream compositions having improved wash-off and antiperspirant efficacy
FR2807022B1 (fr) * 2000-03-28 2002-05-10 Pechiney Electrometallurgie Procede de recuperation de l'energie thermique des gaz d'un four d'electrometallurgie et application a la fabrication de poudre de silice
WO2001085118A2 (en) * 2000-05-12 2001-11-15 Unilever Plc Antiperspirant and/or deodorant compositions
US6410002B2 (en) * 2000-05-12 2002-06-25 Unilever Home & Personal Care Usa Division Of Conopco, Inc. Preparation of antiperspirant gels which obviates the use of simple glycols
GB0019232D0 (en) 2000-08-04 2000-09-27 Unilever Plc Antiperspirant formulations
WO2003026733A2 (en) * 2001-09-28 2003-04-03 Biovalve Technologies, Inc. Microneedle with membrane
US6428777B1 (en) 2002-01-10 2002-08-06 Andrew Jergens Company Low residue water-containing antiperspirant stick
DE10202312A1 (de) * 2002-01-23 2003-07-31 Beiersdorf Ag Kosmetische und dermatologische Pflegeöle mit einem Gehalt an Wachsen
US6979438B2 (en) 2002-01-25 2005-12-27 The Procter & Gamble Company Antiperspirant compositions containing petrolatum
EP1759197A1 (de) * 2004-06-21 2007-03-07 The Procter and Gamble Company Verfahren zur bestimmung der leistung einer schweisshemmenden zusammensetzung
US20070092463A1 (en) * 2005-10-26 2007-04-26 Kim Joo W Semi (soft)-solid antiperspirant compositions
DE102008029004A1 (de) * 2007-06-29 2009-01-02 Rpc Bramlage Gmbh Spender zur Ausgabe flüssiger oder pastöser Massen
DE102008052748A1 (de) 2008-10-22 2010-04-29 Beiersdorf Ag Wasserfreie Antitranspirantstifte mit mikrokistallinem Wachs
US9554982B2 (en) 2012-09-14 2017-01-31 The Procter & Gamble Company Aerosol antiperspirant compositions, products and methods
US20140154197A1 (en) 2012-11-26 2014-06-05 The Procter & Gamble Company Packaged Antiperspirant Compositions
WO2015112487A1 (en) 2014-01-21 2015-07-30 The Procter & Gamble Company Package for antiperspirant compositions
US9579265B2 (en) 2014-03-13 2017-02-28 The Procter & Gamble Company Aerosol antiperspirant compositions, products and methods
US9662285B2 (en) 2014-03-13 2017-05-30 The Procter & Gamble Company Aerosol antiperspirant compositions, products and methods
CA3074837A1 (en) * 2017-09-06 2019-03-14 Martijn Pieter VAN SETERS Deodorant composition

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8630724D0 (en) * 1986-12-23 1987-02-04 Unilever Plc Cosmetic product
US5069897A (en) * 1987-10-16 1991-12-03 The Proctor & Gamble Company Antiperspirant creams
JPH0256411A (ja) * 1988-08-22 1990-02-26 Naohisa Higuchi ケラチン質物質及び皮膚上に適用する、脱臭効果を持つ組成物
US5019375A (en) * 1989-03-14 1991-05-28 The Procter & Gamble Company Low residue antiperspirant creams
US5292530A (en) * 1991-06-02 1994-03-08 Helene Curtis, Inc. Stable anhydrous topically-active composition and suspending agent therefor
DE69109646T2 (de) * 1990-12-21 1996-01-25 Dow Corning Eingekapselte Aluminiumzusammensetzungen.
US5433943A (en) * 1992-12-21 1995-07-18 Osipow; Lloyd I. Deodorant and/or antiperspirant compositions
GB2299506B (en) * 1995-04-03 1999-04-14 Unilever Plc Antiperspirant actives and compositions

Also Published As

Publication number Publication date
CN1262613A (zh) 2000-08-09
JP2001517237A (ja) 2001-10-02
ATE249195T1 (de) 2003-09-15
DE69818034D1 (de) 2003-10-16
DE69818034T2 (de) 2004-07-08
US5843414A (en) 1998-12-01
EP0981324A1 (de) 2000-03-01
BR9809825A (pt) 2000-06-20
WO1998051272A1 (en) 1998-11-19
AU7369398A (en) 1998-12-08

Similar Documents

Publication Publication Date Title
EP0981324B1 (de) Schweisshemmende creme mit verbesserten trockenen hautgefühl
US5718890A (en) Antiperspirant cream compositions comprising select triglyceride gellants
US5069897A (en) Antiperspirant creams
RU2206314C2 (ru) Антиперспирантная липкая композиция с улучшенными характеристиками
US5891424A (en) Antiperspirant cream compositions having improved rheology
US4853214A (en) Antiperspirant creams containing volatile silicones
EP1416910B1 (de) Topische leave-on zusammensetzung enthaltend spezifische pantothensäure-derivate
EP1858596B1 (de) Wasserfreie, schweisshemmende zusammensetzung mit hautschonenden elementen
MXPA06014680A (es) Composiciones antitranspirantes que comprenden ozoquerita.
CA2011565A1 (en) Low residue antiperspirant creams
EP0312270A2 (de) Schweisshemmende Creme und ihre Zubereitung
CZ294791B6 (cs) Kosmetická kompozice bez přidaného mastného alkoholu a vosku z ricinového oleje a aplikační nádobka obsahující tuto kompozici
CA2237526C (en) Antiperspirant cream compositions having improved rheology
CA2455137C (en) Antiperspirant compositions containing film-forming polymers
EP0862409B1 (de) Schweisshemmende cremezusammensetzungen enthaltend triglycerid gelierungsmittel
US6183730B1 (en) Antiperspirant and deodorant compositions containing cyclohexasiloxane
US6488919B1 (en) Semi-solid low residue water-containing antiperspirant composition
US5882637A (en) Antiperspirant cream compositions comprising fatty alcohol gellants
US5902571A (en) Antiperspirant cream compositions comprising select triglyceride gellants
WO1999063962A1 (en) Antiperspirant compositions containing select coupling agents
AU698394B2 (en) Antiperspirant cream compositions comprising select triglyceride gellants
CA2237587C (en) Antiperspirant cream compositions comprising select triglyceride gellants

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 19991206

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH DE DK ES FI FR GB GR IE IT LI LU NL PT SE

17Q First examination report despatched

Effective date: 20020729

GRAH Despatch of communication of intention to grant a patent

Free format text: ORIGINAL CODE: EPIDOS IGRA

GRAH Despatch of communication of intention to grant a patent

Free format text: ORIGINAL CODE: EPIDOS IGRA

GRAA (expected) grant

Free format text: ORIGINAL CODE: 0009210

AK Designated contracting states

Kind code of ref document: B1

Designated state(s): AT BE CH DE DK ES FI FR GB GR IE IT LI LU NL PT SE

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: NL

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20030910

Ref country code: LI

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20030910

Ref country code: IT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT;WARNING: LAPSES OF ITALIAN PATENTS WITH EFFECTIVE DATE BEFORE 2007 MAY HAVE OCCURRED AT ANY TIME BEFORE 2007. THE CORRECT EFFECTIVE DATE MAY BE DIFFERENT FROM THE ONE RECORDED.

Effective date: 20030910

Ref country code: FR

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20030910

Ref country code: FI

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20030910

Ref country code: CH

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20030910

Ref country code: BE

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20030910

Ref country code: AT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20030910

REG Reference to a national code

Ref country code: GB

Ref legal event code: FG4D

REG Reference to a national code

Ref country code: CH

Ref legal event code: EP

REF Corresponds to:

Ref document number: 69818034

Country of ref document: DE

Date of ref document: 20031016

Kind code of ref document: P

REG Reference to a national code

Ref country code: IE

Ref legal event code: FG4D

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: SE

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20031210

Ref country code: GR

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20031210

Ref country code: DK

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20031210

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: PT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20031218

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: ES

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20031221

NLV1 Nl: lapsed or annulled due to failure to fulfill the requirements of art. 29p and 29m of the patents act
REG Reference to a national code

Ref country code: CH

Ref legal event code: PL

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: LU

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20040508

Ref country code: GB

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20040508

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: IE

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20040510

PLBE No opposition filed within time limit

Free format text: ORIGINAL CODE: 0009261

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT

26N No opposition filed

Effective date: 20040614

EN Fr: translation not filed
PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: DE

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20041201

GBPC Gb: european patent ceased through non-payment of renewal fee

Effective date: 20040508

REG Reference to a national code

Ref country code: IE

Ref legal event code: MM4A